Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc REPCF


Primary Symbol: V.RP

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > CIRO
View:
Post by Ingiboy on Mar 13, 2024 1:10pm

CIRO

I think the time has come for some answers.  They can no longer hide behind any legal restrictions.
This is verging on becoming a matter for the Canadian Investment Regulatory Organization (CIRO).

Major decisions are being made regarding Replicel without consulting the shareholders and that is illegal in my view. The time has come for all of us bewildered shareholders to do a full court press on the managment of this company.
The Replicel website lists a phone number:  604 248 8730.

We as a group now need to ask for some answers.
Comment by BellEnd on Mar 13, 2024 4:22pm
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Mar 13, 2024 7:42pm
 I have been hearing this same legal excuse for over 2 months.  It is wearing a bit thin.  And by the way, working on what ?
Comment by BellEnd on Mar 13, 2024 10:06pm
This post has been removed in accordance with Community Policy
Comment by bluemoons20 on Mar 13, 2024 11:00pm
As long as the price is right!!! GLTA
Replicel Life Sciences Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities